Global Healthcare Investing Conference


Leveraging Geography for Competitive Advantage

  2008 Powerpoint Presentations Click Here

CONFERENCE OVERVIEW:

Global healthcare investing is still in its early-stages. In 2007, IBF and BioEnterprise convened the Inaugural Global Healthcare Investing Conference to bring together the leading-edge investors, institutions, and companies that invest in technologies across the world, manage "global" start-ups, and operate in multiple financial and regulatory markets. Building from the success of that initial conference, IBF and BioEnterprise are proud to present the 2nd Annual Global Healthcare Investing Conference to address the needs of this community.

2008 Selected Investors Attending:

  • Aisling Capital
  • Ampersand Ventures
  • Aqua Partners LLC
  • Arboretum Ventures
  • Arcapita Ventures
  • Athenian Venture Partners
  • Birchmere Ventures
  • Bridge Investment Fund LP
  • Bruml Capital
  • Burrill & Company
  • Capital Innovations, Inc.
  • Case Technology Ventures
  • Cleveland Clinic Innovations
  • CRT Capital Group LLC
  • Early Stage Partners
  • East West Capital Partners Pte. Ltd.
  • Fidelity Asia Ventures Ltd
  • Foundation Medical Partners
  • Highland Capital Partners
  • JVax Investment Group
  • L Capital
  • Morgenthaler
  • National City Investments
  • Pamorama Capital
  • Pappas Ventures
  • Primus Capital Funds
  • Radius Ventures
  • River Cities Capital Funds
  • The Riverside Company
  • RiverVest Venture Partners
  • Roberts Mitani
  • S.R. One
  • Siemens Venture Capital
  • Teleflex Incorporated
  • Triathlon Medical Venture Partners
  • Viscogliosi Bros., LLC
  • Western Reserve Partners

2008 Discussion Topic's Include:

  • Developing US Companies Overseas
  • Tapping Global Capital
  • Opportunities in Emerging Geographies
  • Global Distribution Strategies
  • Is it the right time to be in Asia?
  • Bringing Companies into the US

2008 Company Presentations:

  • Non-US based emerging growth companies that have raised at least one round of professional funding.
  • Technologies spanning medical device, diagnostics, delivery, drug discovery, biotechnology, healthcare information technology and services.

Audience Profile:

Attendees include national and international venture capitalists, private equity investors, investment banks, corporate business development executives, emerging growth companies, healthcare service providers, medical device diagnostics, delivery, drug discovery, biotechnology, healthcare information technology and services companies.

2007 CONFERENCE HIGHLIGHTS:

The Inaugural Global Healthcare Investing Conference was an overwhelming success with 250 delegates representing 19 U.S. states and 14 countries. Audience breakdown of:
  • 29% venture capital & private equity firms
  • 31% healthcare companies
  • 8% investment bankers
  • 9% government agencies and foundations
  • The remaining 23% of the audience was a mix of consultants and service providers

Testimonials:

  • "Conference was above expectations - well done"
  • "It was a good experience"
  • "Overall quality and mix of the presenting companies was better than expected"
  • "I came to learn about the investors' experience, which may be somewhat different from other participants. The conference met my needs completely and additionally gave me more info about the state of the services branch of the industry then I was expecting."
  • "Very good and informative; I got exponential "IRR" on my investment during this conference."
  • "Excellent networking event for companies"

Fireside Chat

Anthony G. Viscogliosi Interviewer:
Anthony Viscogliosi
Principal
Viscogliosi & Brothers, LLC
Jayson Pankin Guest Speaker:
Jayson Pankin
New Venture Creation Specialist
Delphi Corporation

 

Platinum Sponsors

Silver Sponsors

Bronze Sponsors

Exhibitors

Sponsorship Inquiries